As a member of Medables board of directors, Mikes know-how in developing scaled SaaS companies will be invaluable as we look to further empower our partners and deliver unsurpassed customer and patient success around the world.. Reify Health provides cloud-based software that accelerates the development of new and life-saving therapies. By minimizing the need for in-person site visits, Medable customers have achieved unprecedented results including 3X faster enrollment and over 90 percent retention rates. Every public company is legally required to install a board of directors; nonprofit organizations and many private companies - while not required to - also name a board of directors. #clinicaltrials #clinicalresearch #healthcare #decentralizedtrials, Within the last decade, electronic clinical outcome assessments (eCOAs) have begun replacing their hard copy alternatives. New Hire to Lead Research for Decentralized Trials | Medable This cookie is set by GDPR Cookie Consent plugin. Medable CEO, Founder, Key Executive Team, Board of Directors & Employees #clinicaltrials #clinicalresearch #healthcare #education, Breaking down barriers to increase patient access to clinical trials - a crucial step towards advancing medical research and improving healthcare for all. He shepherded five successful IPOs as CFO, venture partner or audit chair, including Okta, RingCentral, Aruba Networks, Riverbed and Polycom. I am thrilled to join Michelle and Medables brilliant team of powerhouse leaders as they drive Medable to unprecedented heights in the health tech industry.. The company brought in a new capital infusion of $304 million in Series D funding last October its fourth round since 2020 to reach a valuation of $2.1 billion. Mike Kourey has been working as a Member of the Board of Directors for Medable, Inc for 306 days. This cookie is set by GDPR Cookie Consent plugin. This cookie is set by GDPR Cookie Consent plugin. It does not correspond to any user ID in the web application and does not store any personally identifiable information. And with more than one million participants currently on the Medable platform, Dr. Tenaerts will create ways to keep participants engaged for potential future clinical trial participation. Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The companys digital platform streamlines design, recruitment, retention and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Decentralizing trials with the Medable platform offers a reality where clinical trials are deployed for many more to participate, and for actionable evidence to be generated reliably, seamlessly and faster than current models.. Mike Kourey, a Veteran Saas Finance Executive, Has Been Appointed to Dr. Tenaerts brings more than 30 years of clinical research experience to Medable, most recently as executive director of the Clinical Trials Transformation Initiative (CTTI) at Duke University. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. Cognizant today announced a partnership with Medable Inc. to jointly deliver clinical research solutions based on Medable's software-as-a-service platform for decentralized clinical trials.. Cognizant will provide Medable with strategic advisory services, technology deployment and best-in-class global support to help Medable customers reduce clinical trial timelines, improve the patient . Medable, Inc | LinkedIn 1) The ability to apply the best practices of hybrid trials to your upcoming studies. You also have the option to opt-out of these cookies. Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes. Lisa Barbadora, Big Valley Marketing for Medable, +1 (610) 420-3413, media@medable.com. Dont sell or share my personal information. Dr. Tenaerts is one of the leading advocates for innovation in clinical trials, with a unique personal background as a clinical trials investigator, hospital research administrator and academic in both the U.S. and Europe. Leverage Novel Options in Oncology Clinical Trial Design to Reduce Burden For Patients and Sites, Quality by Design: How eCOA improves oversight and participant data quality, Why the future looks bright for eCOA in Clinical Trials, Medable makes oncology trials more efficient (5 minute read), How to Supercharge Real World Evidence Generation in Phase IV Trials, Bridging the Gap: Ensuring Sites are Successful With Medable, How Hybrid and Decentralized Technologies Impact Each Phase of the Clinical Research Journey. ________ Dr. Longmire is mission driven to accelerate the development of new therapies for disease. However, you may visit "Cookie Settings" to provide a controlled consent. Pams experience in every trial processseeing traditional trial hurdles first-hand while also having an industry-wide view of how trials are changingwill allow our team and our partners to quickly identify pain points so physicians can focus more on patient needs.. Medable experienced record growth in 2020 as the COVID-19 pandemic drove demand for remote clinical trial technologies. The company brought in a new capital infusion of $304 million in Series D funding last October its fourth round since 2020 to reach a valuation of $2.1 billion. Doctor of Chiropractic at Parker Wellness Center- Board of Directors Global Tek MD Denver, CO. Jeff Parker President at Parker Industries, Inc. . Dr. Tenaerts will lead the scientific office at Medable to drive advancement of decentralized research methodologies with evidence-based best practices. About Us - Decentralized Clinical Trial Platform Provider | Medable I am thrilled to join Michelle and Medables brilliant team of powerhouse leaders as they drive Medable to unprecedented heights in the health tech industry.. The platform gives real-time visibility into clinical data, enabling sponsors to file New Drug Applications (NDAs) more efficiently to bring drugs to market faster and at lower costs. Org Chart Medable - The Official Board Active partnerships with Board participation include Medable, Orbita, Veda, RxLightning, CancerIQ, and InsightRx. We are committed to powering research for every body and every biology. Decentralizing trials with the Medable platform offers a reality where clinical trials are deployed for many more to participate, and for actionable evidence to be generated reliably, seamlessly and faster than current models.. Medable experienced record growth in 2020 as the COVID-19 pandemic drove demand for remote clinical trial technologies. I am thrilled to join Michelle and Medables brilliant team of powerhouse leaders as they drive Medable to unprecedented heights in the health tech industry.. For more information, visit www.medable.com and follow @Medableinc on Twitter. This cookie is installed by Google Analytics. Medable CEO and co-founder, Dr. Michelle Longmire, said: The Medable SaaS platform enables leading life sciences companies to drive adoption of decentralised clinical trials at an enterprise level. Hady Khoury - Chief Development Officer (CDO) - Medable, Inc | LinkedIn Hady Khoury Chief Development Officer at Medable, Inc. Kourey was also CFO of Vlocity when it was acquired by Salesforce. Medable Hires Dr. Pamela Tenaerts as Chief Scientific Officer to Lead Stanford University, Stanford Health Care, National Institutes of Health, Los Alamos National Laboratory, and University of New Mexico. Developer of a cloud-based platform designed to provide effective therapies to patients. He shepherded five successful IPOs as CFO, venture partner or audit chair, including Okta, RingCentral, Aruba Networks, Riverbed and Polycom. She is on the board of directors for the Society for Clinical Trials, and the Scientific Leadership Board for the Digital Medicine Society (DiME). Which best describes your interest in health tech? Keep up-to-date with the latest tech news and read in-depth features by subscribing to our newsletter and attending our events. Medable is changing the game when it comes to clinical trials and drug development focusing on equitable, patient-first decentralized and hybrid studies designed to measure the true impact of therapies in real-world settings, Kourey said. According to their documentation, whenever HubSpot changes the session cookie, this cookie is also set to determine if the visitor has restarted their browser. The company has designed a neighborhood-based search, information and diary management tool that facilitates the interaction between doctor and patient. Pams leadership will be vital to bringing innovation, evidence and best practices to fuel the future of patient-centered clinical research, said Dr. Michelle Longmire, CEO and co-founder of Medable. He also was a partner at Khosla Ventures. Dr. Tenaerts joins Medable from Duke, where she led CTTIs efforts to develop and drive adoption of practices that increase the quality and efficiency of clinical trials. The Medable SaaS platform enables leading life sciences companies to drive adoption of decentralized clinical trials at an enterprise level, said Medable CEO and co-founder Dr. Michelle Longmire. She will evolve best practices and bring clinical insight into Medables continued work on a master protocol approach to multi-study research. PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading SaaS platform for patient-centered clinical trials, today announced the appointment of enterprise software veteran and Dialpad CFO Mike Kourey to its board of directors. In his more than 25 years of experience, Kourey has had a significant track record in helping hyper-growth companies scale. ELITE 2022 Talent Acquisition Leader MJ Vigil of Medable Medable is a privately held, venture-backed company headquartered in Palo Alto, California. Prior to CTTI, Dr. Tenaerts oversaw European operations for CoAxia, a medical device company focused on cerebral ischemia. Michelle Longmire - Medable, Inc He holds an MBA from Santa Clara University and a bachelors degree from the University of California, Davis. Emre Ozcan,VP, Global Head ofDigital Health,Merck Thomas Hummel - Fresenius Kabi The digital platform streamlines design, recruitment, retention and data quality for decentralised trials, replacing siloed systems with integrated digital tools, data and interfaces. Medable is a privately held, venture-backed company headquartered in Palo Alto, California. This website uses cookies to improve your experience while you navigate through the website. To ensure the most secure and best overall experience on our website we recommend the latest versions of, Internet Explorer is no longer supported. Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet. View our latest use case to see how we eliminated manual & duplicative work to make an oncology trial easier & more efficient for all stakeholders, using eCOA, IRT, & templatization standardization. This depth of experience will drive tremendous value for Medables stakeholders, and mostly importantly, patients worldwide. Sign up for free updates from Health Tech World. April 8, 2022 By Gordon Stribling US clinical trials platform Medable has announced the appointment of Mike Kourey to its board of directors. He holds an MBA from Santa Clara University and a bachelors degree from the University of California, Davis. As a member of Medables board of directors, Mikes know-how in developing scaled SaaS companies will be invaluable as we look to further empower our partners and deliver unsurpassed customer and patient success around the world.. James Sas Co-Founder & Chief Architect Michelle Longmire Co-Founder & CEO Tim Smith Co-Founder & CTO Fernando Waigandt Director of Mobile Development Alison Holland Head of Decentralised Clinical Trials Eric M. Peper EVP Sales US clinical trials platform Medable has announced the appointment of Mike Kourey to its board of directors. Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes. Kourey, who brings unparalleled expertise in scaling both public and private enterprise software companies, will help guide Medable's continued rise as a leader in the health technology As Medables chief scientific officer, Dr. Tenaerts will lead evidence collection around patient centricity, efficiency and quality in decentralized trials. Taha started his journey at the Texas Medical Center (TMC), the world's largest medical center. Kourey is the latest addition to Medables growing employee roster. The purpose of the cookie is to keep track of sessions. Medable believes in solving one of the longest-standing challenges in healthcare: access to clinical trials. We are inspired by science and humans. Medable Inc., the leading SaaS platform for patient-centered clinical trials, today announced the appointment of enterprise software veteran and Dialpad CFO Mike Kourey to its board of directors.
Frank Lucas Nephew Baseball,
Philadelphia Police Non Emergency Number,
Celebrities With Dead Eyes,
Articles M